IL6 and Patent ductus arteriosus: Taken together, these data indicate that TGFβ induces the secretion of IL‐6 from CAFs to inhibit the NK cell activity, and inhibition of stromal TGFβ signaling or IL‐6 rescues NK cell activity, resulting in reduced PDA progression.